Evidence map›Paper›PMID 33771996›Full record

ArticleNature communications2021

Bora phosphorylation substitutes in trans for T-loop phosphorylation in Aurora A to promote mitotic entry.

N Tavernier, Y Thomas, S Vigneron, P Maisonneuve, S Orlicky, P Mader, S G Regmi, L Van Hove, N M Levinson, G Gasmi-Seabrook and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. GWAS-Identified SNPs and Candidate Genes Influencing Sex in Loach (Animals : an open access journal from MDPI · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

N TavernierCentre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Y ThomasProgramme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France.
S VigneronCentre de Recherche de Biologie cellulaire de Montpellier, UMR 5237, Université de Montpellier, CNRS, Montpellier, France.
P MaisonneuveCentre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.ORCID 0000-0001-8292-5741
S OrlickyCentre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
P MaderCentre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
S G RegmiEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
L Van HoveProgramme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France.
N M LevinsonDepartment of Pharmacology, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0003-4338-8087
G Gasmi-SeabrookPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
N JolyProgramme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France.
M PoteauInstitut Gustave Roussy CNRS UMR9019, Villejuif, France.
G Velez-AguileraProgramme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France.
O GavetInstitut Gustave Roussy CNRS UMR9019, Villejuif, France.
A CastroCentre de Recherche de Biologie cellulaire de Montpellier, UMR 5237, Université de Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-3655-1352
M DassoEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.ORCID 0000-0002-5410-1371
T LorcaCentre de Recherche de Biologie cellulaire de Montpellier, UMR 5237, Université de Montpellier, CNRS, Montpellier, France.
F Sicheri *Centre for Systems Biology, Lunenfeld Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada. sicheri@lunenfeld.ca.ORCID 0000-0002-9824-2117
L Pintard *Programme équipe Labellisée Ligue Contre le Cancer, Institut Jacques Monod, UMR7592, Université de Paris, CNRS, Paris, France. Lionel.pintard@ijm.fr.ORCID 0000-0003-0286-4630
Centre National de la Recherche Scientifique · FRLunenfeld-Tanenbaum Research Institute · CANational Institutes of Health · USUniversity Health Network · CAUniversity of Minnesota · USUniversity of Toronto · CA

Funding

Mitotic roles of the Nuclear Transport MachineryZIAHD008954 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DASSO, MARY C. · 2015 to 2025
$25.3M
CIHR FDN 143277CIHR FRN 414829CIHR MFE 152464
6 · The paper itself

Abstract

Polo-like kinase 1 (Plk1) is instrumental for mitotic entry and progression. Plk1 is activated by phosphorylation on a conserved residue Thr210 in its activation segment by the Aurora A kinase (AURKA), a reaction that critically requires the co-factor Bora phosphorylated by a CyclinA/B-Cdk1 kinase. Here we show that phospho-Bora is a direct activator of AURKA kinase activity. We localize the key determinants of phospho-Bora function to a 100 amino acid region encompassing two short Tpx2-like motifs and a phosphoSerine-Proline motif at Serine 112, through which Bora binds AURKA. The latter substitutes in trans for the Thr288 phospho-regulatory site of AURKA, which is essential for an active conformation of the kinase domain. We demonstrate the importance of these determinants for Bora function in mitotic entry both in Xenopus egg extracts and in human cells. Our findings unveil the activation mechanism of AURKA that is critical for mitotic entry.

Indexed as

MitosisAmino Acid MotifsAnimalsAurora Kinase ACell Cycle ProteinsCell Line, TumorCyclin A2Cyclin-Dependent Kinase 2Enzyme ActivationFemaleHumansOocytesPhosphorylationPolo-Like Kinase 1ProlineProtein Serine-Threonine KinasesAurora Kinase Abora protein, humanCDK2 protein, humanCell Cycle ProteinsCyclin A2Cyclin-Dependent Kinase 2Polo-Like Kinase 1ProlineProtein Serine-Threonine KinasesProto-Oncogene ProteinsSerineThreonine

Identifiers

PMID33771996
PMCPMC7997955
OpenAlexW3136855762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.